diabetes
Takeda delays diabetes drug in Europe
June 4, 2009Research and Development, Sales and Marketing Takeda, diabetes
Takeda is to delay seeking European approval of its key drug candidate alogliptin, and instead take another two years to …
Novo Nordisk plans summer launches for new diabetes drug
May 7, 2009Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes
Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …
Mannkind picks up Pfizer’s Exubera facility
March 16, 2009Manufacturing and Production Mannkind, diabetes
The demise of Pfizer's inhaled diabetes treatment Exubera cast a pall over the prospects for inhaled insulin therapy, but has …
GSK’s diabetes candidate enters phase III
February 19, 2009Research and Development GSK, diabetes
A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …
Sanofi-Aventis joins YouTube revolution
February 18, 2009Sales and Marketing Sanofi-Aventis, diabetes
Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …
Lilly launches diabetes patient education programme
September 12, 2008Medical Communications, Sales and Marketing diabetes, patients
Lilly has launched an international diabetes education programme, the centrepiece of which is a tool for healthcare professionals to conduct …
Delayed Galvus cleared for 2008 European launch
December 19, 2007Sales and Marketing EU, diabetes
A key European regulatory committee has approved revised labelling for Novartis' diabetes drug Galvus, paving the way for a 2008 …
Avandia suffering less in Europe
December 10, 2007Sales and Marketing Avandia, diabetes
New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …
Dwindling sales mean job cuts at GSK
October 25, 2007Sales and Marketing Avandia, diabetes
GlaxoSmithKline saw sales in its pharmaceutical division dip 2% in the third quarter, as falling demand for Avandia continued to …
Pfizer abandons Exubera
October 19, 2007Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …
FDA allows Avandia to stay but damage already done
August 3, 2007Sales and Marketing diabetes
An FDA advisory committee has recommended that GlaxoSmithKline's diabetes treatment Avandia should remain available on the US market, albeit with …
Avandia scare casts doubt over its future for Alzheimer’s
June 13, 2007Sales and Marketing Avandia, diabetes, safety
New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …
Januvia launched in UK
April 25, 2007Sales and Marketing Januvia, diabetes
Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …
Diabetes UK report criticises cutbacks in NHS
March 23, 2007diabetes
In a new report, Diabetes UK has criticised cutbacks in NHS diabetes treatment, suggesting that service reductions are putting patients' …
New diabetes drug launched in UK
March 14, 2007Sales and Marketing Byetta, diabetes
A new diabetes medicine, which mimics the body's natural processes for controlling blood sugar, has been launched in the UK.The …
